XML 117 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Tables)
 9 Months Ended
Jun. 30, 2013
Roche Madison Inc
  
Summary of Estimated Fair Values at Date of Acquisition

The following table summarizes the estimated fair values at the date of acquisition:

 

Current assets

$

  432,709

  

Property and equipment

 

  7,215,206

  

Intangible assets

 

  1,174,935

  

Other noncurrent assets

 

  6,264

  

Current liabilities

 

(414,122

) 

Noncurrent liabilities

 

(1,570,072

) 

Gain on purchase

 

(1,576,106

) 

Total purchase consideration

$

  5,268,814

  

 
Purchase Consideration

The purchase consideration was composed of the following:

 

Promissory note due Roche

$

  50,000

  

Contingent consideration

 

  84,935

  

Shares issued to Roche

 

  5,133,879

  

Total purchase consideration

$

  5,268,814

  

 
Alvos acquisition
  
Summary of Estimated Fair Values at Date of Acquisition

The following table summarizes the estimated fair values at the date of acquisition:

 

Current assets

$

  29,332

  

In-process R&D

 

  2,172,387

  

Current liabilities

 

(113,033

) 

Total purchase consideration

$

  2,088,686

  

 
Purchase Consideration

The purchase consideration was comprised of shares of Arrowhead Common Stock issued to the former shareholders of Alvos Therapeutics, Inc.

 

Shares issued

 

  315,457

  

Price per share

$

  6.34

  

Share consideration

$

  2,000,000

  

Contingent consideration

$

  88,686

  

Total purchase consideration

$

  2,088,686